NO995842L - Multicykliske erytromycinderivater - Google Patents

Multicykliske erytromycinderivater

Info

Publication number
NO995842L
NO995842L NO995842A NO995842A NO995842L NO 995842 L NO995842 L NO 995842L NO 995842 A NO995842 A NO 995842A NO 995842 A NO995842 A NO 995842A NO 995842 L NO995842 L NO 995842L
Authority
NO
Norway
Prior art keywords
compound
pharmaceutically acceptable
effective amount
therapeutically effective
erythromycin derivatives
Prior art date
Application number
NO995842A
Other languages
English (en)
Norwegian (no)
Other versions
NO995842D0 (no
Inventor
Yat Sun Or
George W Griesgraber
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO995842D0 publication Critical patent/NO995842D0/no
Publication of NO995842L publication Critical patent/NO995842L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO995842A 1997-05-29 1999-11-29 Multicykliske erytromycinderivater NO995842L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86545397A 1997-05-29 1997-05-29
PCT/US1998/010501 WO1998054197A1 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO995842D0 NO995842D0 (no) 1999-11-29
NO995842L true NO995842L (no) 2000-01-26

Family

ID=25345545

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995842A NO995842L (no) 1997-05-29 1999-11-29 Multicykliske erytromycinderivater

Country Status (26)

Country Link
EP (1) EP0984975B1 (es)
JP (1) JP4368950B2 (es)
KR (1) KR20010013041A (es)
CN (1) CN1258299A (es)
AR (1) AR013081A1 (es)
AT (1) ATE238330T1 (es)
AU (1) AU7591298A (es)
BG (1) BG103985A (es)
BR (1) BR9809489A (es)
CA (1) CA2290421C (es)
CO (1) CO4950620A1 (es)
DE (1) DE69813798T2 (es)
DK (1) DK0984975T3 (es)
ES (1) ES2197472T3 (es)
HU (1) HUP0004809A3 (es)
IL (1) IL132482A0 (es)
MX (1) MXPA99011001A (es)
NO (1) NO995842L (es)
NZ (1) NZ500531A (es)
PL (1) PL337066A1 (es)
PT (1) PT984975E (es)
SI (1) SI0984975T1 (es)
SK (1) SK160299A3 (es)
TR (1) TR199902820T2 (es)
WO (1) WO1998054197A1 (es)
ZA (1) ZA984488B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181300B1 (en) * 1999-06-07 2003-09-17 Abbott Laboratories 6-o-carbamate ketolide derivatives
US20100035832A1 (en) * 2005-01-12 2010-02-11 Alpharma Aps Macrolides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662420B2 (en) * 1992-04-22 1995-08-31 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide A derivative
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
SI0984975T1 (en) 2004-02-29
DE69813798D1 (en) 2003-05-28
NZ500531A (en) 2001-07-27
DK0984975T3 (da) 2003-08-11
JP2002500669A (ja) 2002-01-08
PL337066A1 (en) 2000-07-31
WO1998054197A1 (en) 1998-12-03
MXPA99011001A (es) 2003-09-10
SK160299A3 (en) 2000-06-12
ES2197472T3 (es) 2004-01-01
CA2290421C (en) 2007-05-08
JP4368950B2 (ja) 2009-11-18
DE69813798T2 (de) 2004-02-19
BR9809489A (pt) 2000-06-20
ATE238330T1 (de) 2003-05-15
KR20010013041A (ko) 2001-02-26
HUP0004809A2 (hu) 2001-05-28
ZA984488B (en) 1998-12-02
BG103985A (en) 2000-07-31
AU7591298A (en) 1998-12-30
IL132482A0 (en) 2001-03-19
AR013081A1 (es) 2000-12-13
CN1258299A (zh) 2000-06-28
TR199902820T2 (xx) 2000-04-21
CO4950620A1 (es) 2000-09-01
PT984975E (pt) 2003-09-30
EP0984975A1 (en) 2000-03-15
NO995842D0 (no) 1999-11-29
HUP0004809A3 (en) 2001-11-28
EP0984975B1 (en) 2003-04-23
CA2290421A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
NO20001169L (no) 6,9-bro erythromycinderivater
NO20002099L (no) 6,11-bro-erytromycinderivater
ES2151599T3 (es) Acidos hidroxamicos substituidos con arilsulfonamido como inhibidores de matriz metaloproteinasas.
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
PT1058683E (pt) Inibidores da farnesil-transferase com uma estrutura de piperidina e seu processo de preparacao
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
NO20001439L (no) 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
PT928788E (pt) Compostos farmaceuticamente activos
NO996108L (no) 9-oksinerytromycinderivater
CA2307788A1 (en) 2-halo-6-o-substituted ketolide derivatives
NO20053483L (no) 4-Anilinokinazolinderivater for behandling av unormal cellevekst
WO2000026224A3 (en) Novel macrolide antibiotics
AU7263591A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
CA2327775A1 (en) 15-membered lactams ketolides with antibacterial activity
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
NO995842L (no) Multicykliske erytromycinderivater
CA2382654A1 (en) Novel a-500359 derivatives
NO942181L (es)
MXPA05008190A (es) Derivado de oligosacarido.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application